300858 logo

Beijing Scitop Bio-tech Co., Ltd. Stock Price

SZSE:300858 Community·CN¥4.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300858 Share Price Performance

CN¥0
-16.12 (-100.00%)
CN¥0
-16.12 (-100.00%)
Price CN¥0

300858 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
1 Reward

Beijing Scitop Bio-tech Co., Ltd. Key Details

CN¥351.5m

Revenue

CN¥154.4m

Cost of Revenue

CN¥197.1m

Gross Profit

CN¥97.7m

Other Expenses

CN¥99.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.38
56.08%
28.28%
0%
View Full Analysis

About 300858

Founded
2003
Employees
295
CEO
Xiaojun Liu
WebsiteView website
www.scitop.cn

Beijing Scitop Bio-tech Co., Ltd. researches, develops, produces, and sells probiotic, postbiotics, and microecologival preparations for animals and plants in China. It provides probiotic and postbiotics for gastrointestinal health, immune regulation, oral health, sleep aid and stress relief, women’s health, slimming and fat reduction, kidney and liver protection, blood sugar regulation, allergy relief, blood pressure regulation, and mother-infant transmission, as well as exercise, bone, heart, and skin health applications. The company also offers microecological preparations and related application technologies for ruminants, monogastric livestock and poultry animals, aquatic animals, and pets. In addition, it develops and promotes microbial agents, such as microbial fertilizers, bio-organic fertilizers, organic material decomposition agents, etc. for vegetable, fruit, edible fungus, forage grass, and crop planting. Beijing Scitop Bio-tech Co., Ltd. was founded in 2003 and is headquartered in Beijing, China.

Recent 300858 News & Updates

Recent updates

No updates